Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05844865 · ClinicalTrials.gov registry record · NA
Patient Derived Vascularized MicroTumor Model of Gastrointestinal Peritoneal Carcinomatosis
A NA study of Peritoneal Carcinomatosis and Gastrointestinal Peritoneal Carcinomatosis, sponsored by University of California, Irvine.
- Recruiting
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT05844865: Recruiting NA study of Peritoneal Carcinomatosis and Gastrointestinal Peritoneal Carcinomatosis, sponsored by University of California, Irvine.
NCT05844865 is a NA study of Peritoneal Carcinomatosis and Gastrointestinal Peritoneal Carcinomatosis that is actively recruiting participants, run by University of California, Irvine. The registered enrollment target is 20 participants, below the 58-participant average among 14 other Peritoneal Carcinomatosis trials with a reported enrollment target (66% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05844865, a NA study of Peritoneal Carcinomatosis and Gastrointestinal Peritoneal Carcinomatosis, is actively recruiting participants, sponsored by University of California, Irvine.
- RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a pilot study gathering and using samples and data from patients with gastrointestinal peritoneal carcinomatosis. Participants will be asked for permission to provide blood and ascites/peritoneal wash fluid, tumor samples during their planned surgical procedure.
Primary Outcome
Establishment and evaluation of angioarchitecture of peritoneal lesions through OCTA imaging obtained during surgery.
Conditions Studied
Interventions
- OTHER Biospecimen Collection (Blood, Ascites/Peritoneal Wash Fluid and/or Tumor Samples)
Study Locations (1)
California
- Chao Family Comprehensive Cancer Center, University of California, Irvine - Orange
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2023-05-04 |
| Est. Completion | 2026-12 |
| Phase | NA |
What NCT05844865 shows while recruiting
NCT05844865 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 58-participant average among 14 other Peritoneal Carcinomatosis trials with a reported enrollment target (66% lower).
The record links to 2 conditions, with Peritoneal Carcinomatosis appearing as the primary indexed condition, and to 1 intervention - of which Biospecimen Collection (Blood, Ascites/Peritoneal Wash Fluid and/or Tumor Samples) is the first listed.
NCT05844865 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05844865 about?
NCT05844865 is a clinical study titled "Patient Derived Vascularized MicroTumor Model of Gastrointestinal Peritoneal Carcinomatosis". This is a pilot study gathering and using samples and data from patients with gastrointestinal peritoneal carcinomatosis. Participants will be asked for permission to provide blood and ascites/peritoneal wash fluid, tumor samples during their planned surgical procedure.
What is the current status of trial NCT05844865?
This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2023-05-04. Estimated completion is 2026-12.
What conditions does trial NCT05844865 study?
This clinical trial studies the following conditions: Peritoneal Carcinomatosis, Gastrointestinal Peritoneal Carcinomatosis.
What interventions are being tested in trial NCT05844865?
The interventions under investigation include: Biospecimen Collection (Blood, Ascites/Peritoneal Wash Fluid and/or Tumor Samples) (OTHER).
Who is sponsoring clinical trial NCT05844865?
This trial is sponsored by University of California, Irvine, which has 368 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05844865 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Peritoneal Carcinomatosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05844865's enrollment target sits among peer trials
20 10th of 14 higher than 5 of 14 other Peritoneal Carcinomatosis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Peritoneal Carcinomatosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Peritoneal Carcinomatosis Leveraging ctDNA Guided Treatment in GI Cancer Study (PERICLES Study)
RECRUITING · NA
-
Individualized Response Assessment to Heated Intraperitoneal Chemotherapy (HIPEC) for the Treatment of Peritoneal Carcinomatosis From Ovarian, Colorectal, Appendiceal, or Peritoneal Mesothelioma Histologies
RECRUITING · Phase 1
-
A Study of Radspherin® in Patients With Primary Advanced Epithelial Cancer, With Peritoneal Metastasis That Are Homologous Recombination Proficient Scheduled to Undergo Neoadjuvant Chemotherapy and Interval Debulking Surgery
RECRUITING · Phase 2
-
Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
RECRUITING · Phase 2
-
Heated Versus Aerosol-based Laparoscopic Chemotherapy for Cancer That Has Spread to the Peritoneum (Abdominal Lining)
RECRUITING · Phase 2
-
Surgery and Heated Intraperitoneal Chemotherapy for Adrenocortical Carcinoma
RECRUITING · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI